F&P Healthcare (FPH): January Revenue Proxy – Seasonally Weak(Er)
Consistent with historical seasonality, January 2023 respiratory export data has fallen sharply versus December 2022; Key takeaways are (1) China respiratory exports remained elevated but saw a sharp decline from December 2022, and (2) North America exports were softer than typical seasonality suggests, which likely reflects the unwind of inventory following the abnormally strong flu/RSV season
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Forsyth Barr
New Zealand Professional Investment Services Firm
Price Chart(Sign Up to Access)
- F&P Healthcare (FPH): January Revenue Proxy – Seasonally Weak(Er)06 Mar 2023
x